Literature DB >> 25621360

Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.

Mohamed Aiyaz, Chand Bipin, Vinay Pantulwar, Raja Mugasimangalam, Crystal A Shanley, Diane J Ordway, Ian M Orme.   

Abstract

In this study we conducted a microarray-based whole genomic analysis of gene expression in the lungs after exposure of guinea pigs to a low dose aerosol of the Atypical Beijing Western Cape TT372 strain of Mycobacterium tuberculosis, after harvesting lung tissues three weeks after infection at a time that effector immunity is starting to peak. The infection resulted in a very large up-regulation of multiple genes at this time, particularly in the context of a "chemokine storm" in the lungs. Overall gene expression was considerably reduced in animals that had been vaccinated with BCG two months earlier, but in both cases strong signatures featuring gamma interferon [IFNγ] and tumor necrosis factor [TNFα] were observed indicating the potent TH1 response in these animals. Even though their effects are not seen until later in the infection, even at this early time point gene expression patterns associated with the potential emergence of regulatory T cells were observed. Genes involving lung repair, response to oxidative stress, and cell trafficking were strongly expressed, but interesting these gene patterns differed substantially between the infected and vaccinated/infected groups of animals. Given the importance of this species as a relevant and cost-effective small animal model of tuberculosis, this approach has the potential to provide new information regarding the effects of vaccination on control of the disease process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25621360      PMCID: PMC4315170          DOI: 10.1016/j.tube.2014.10.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  36 in total

1.  Mechanisms of vaccine-induced resistance in a guinea pig model of pulmonary tuberculosis.

Authors:  D N McMurray; G Dai; S Phalen
Journal:  Tuber Lung Dis       Date:  1999

Review 2.  Preclinical testing of new vaccines for tuberculosis: a comprehensive review.

Authors:  Ian M Orme
Journal:  Vaccine       Date:  2005-08-08       Impact factor: 3.641

Review 3.  Pathogenesis of experimental tuberculosis in animal models.

Authors:  D N McMurray; F M Collins; A M Dannenberg; D W Smith
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

4.  Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Authors:  Hans-Joachim Mollenkopf; Karin Hahnke; Stefan H E Kaufmann
Journal:  Microbes Infect       Date:  2005-08-22       Impact factor: 2.700

5.  Influence of BCG vaccination on the pathogenesis of experimental airborne tuberculosis.

Authors:  D W Smith; J S Fok; R S Ho; G E Harding; E Wiegeshaus; P K Arora
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1975

6.  Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.

Authors:  Ann Williams; Graham J Hatch; Simon O Clark; Karen E Gooch; Kim A Hatch; Graham A Hall; Kris Huygen; Tom H M Ottenhoff; Kees L M C Franken; Peter Andersen; T Mark Doherty; Stefan H E Kaufmann; Leander Grode; Peter Seiler; Carlos Martin; Brigitte Gicquel; Stewart T Cole; Priscille Brodin; Alexander S Pym; Wilfried Dalemans; Joe Cohen; Yves Lobet; Nilu Goonetilleke; Helen McShane; Adrian Hill; Tanya Parish; Debbie Smith; Neil G Stoker; Douglas B Lowrie; Gunilla Källenius; Stefan Svenson; Andrzej Pawlowski; Karen Blake; Philip D Marsh
Journal:  Tuberculosis (Edinb)       Date:  2005-01-20       Impact factor: 3.131

7.  Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.

Authors:  Julia A Tree; Michael J Elmore; Sajid Javed; Ann Williams; Philip D Marsh
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

8.  CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration.

Authors:  Holly M Scott Algood; JoAnne L Flynn
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

9.  Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis.

Authors:  Mark J Lyons; Teizo Yoshimura; David N McMurray
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

10.  Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.

Authors:  Crystal A Shanley; Elizma M Streicher; Robin M Warren; Thomas C Victor; Ian M Orme
Journal:  Vaccine       Date:  2013-10-19       Impact factor: 3.641

View more
  2 in total

1.  GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.

Authors:  Thomas H King; Crystal A Shanley; Zhimin Guo; Donald Bellgrau; Timothy Rodell; Synthia Furney; Marcela Henao-Tamayo; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

2.  Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.

Authors:  Crystal A Shanley; Marcela I Henao-Tamayo; Chand Bipin; Raja Mugasimangalam; Deepshika Verma; Diane J Ordway; Elizabeth M Streicher; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2018-02-09       Impact factor: 3.131

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.